Related content

Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma

By Kurt Mevlut   Onal Ibrahim   Elkiran Tamer   Altun Bulent   Altundag Kadri   Gullu Ibrahim  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 203-206

Humana Press, Inc

Access to resources Recommend Favorite

Zoledronic acid in lung cancer with bone metastases: a review

By Isla Dolores   Afonso Ruth   Bosch-Barrera Joaquim   Martínez Natividad  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 421-426

Informa Healthcare

Access to resources Recommend Favorite

Isolated spleen recurrence in a patient with lung adenocarcinoma: A case report

By            

Experimental and Therapeutic Medicine, Vol. 10, Iss. 2, 2015-01 ,pp. : 733-736

Spandidos Publications

Access to resources Recommend Favorite

Re-administration of gefitinib following diffuse interstitial lung disease in a patient with advanced lung adenocarcinoma: A case report and review of the literature

By        

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2419-2421

Spandidos Publications

Access to resources Recommend Favorite

Responses to crizotinib in a patient with c-ros oncogene 1, receptor tyrosine kinasepositive advanced lung adenocarcinoma: A case report

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2624-2626

Spandidos Publications

Access to resources Recommend Favorite